Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.

Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis. Br J Dermatol. 2020 Apr 05;: Authors: Steeb T, Heppt MV, Berking C PMID: 32249410 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32249410?dopt=Abstract

Source: The British Journal of Dermatology - April 4, 2020 Category: Dermatology Authors: Steeb T, Heppt MV, Berking C Tags: Br J Dermatol Source Type: research

More News: Dermatology | Skin | UK Health